Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Additional Information (Detail)

v3.24.1
Summary of Significant Accounting Policies - Additional Information (Detail)
 12 Months Ended
Sep. 18, 2023
$ / shares
Sep. 13, 2023
USD ($)
$ / shares
shares
May 26, 2023
$ / shares
May 24, 2023
USD ($)
$ / shares
shares
Jun. 08, 2020
$ / shares
shares
Dec. 31, 2023
USD ($)
Segment
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Feb. 10, 2021
$ / shares
shares
Dec. 31, 2020
shares
Jul. 23, 2020
shares
Accounting Policies [Line Items]                      
Depreciation expense | $           $ 2,800,000 $ 500,000 $ 400,000      
Number of reporting segment | Segment           1          
Convertible preferred stock, shares issued and sold           1,000,000          
Common stock, par value | $ / shares           $ 0.001 $ 0.001        
Share price | $ / shares                 $ 2,575    
Preferred stock, shares issued           1,000,000          
Revenue from products and services transferred to customers, percentage           89.00% 88.00% 88.00%      
Revenue from services transferred to customers over time, percentage           11.00% 12.00% 12.00%      
Contract With Customer Liability Deferred Revenue Undelivered Elements | $           $ 400,000 $ 400,000        
Contract With Customer Liability Revenue Recognized Undelivered Elements | $           400,000 800,000        
Extended warranties recognized | $           1,300,000 1,400,000        
Advertising costs | $           800,000 1,500,000 $ 1,400,000      
Compensation cost related to stock options | $           1,232,000 2,303,000 $ 1,662,000      
Total unrecognized compensation cost | $           $ 400,000 1,000,000        
Unrecognized share based compensation cost to be recognized over weighted-average period           1 year 1 month 6 days          
Valuation allowance | $           $ (35,806,000) $ (31,235,000)        
Outstanding stock options, restricted stock units and warrants excluded from diluted loss per share           4,061,000,000 27,000,000 9,000,000      
Shares issued           3,416,000 77,000        
Forfeiture Rate One                      
Accounting Policies [Line Items]                      
Fair value assumptions, forfeiture rate           7.87% 10.87% 10.91%      
Forfeiture Rate Two                      
Accounting Policies [Line Items]                      
Fair value assumptions, forfeiture rate           30.38% 10.91% 25.91%      
Forfeiture Rate Three                      
Accounting Policies [Line Items]                      
Fair value assumptions, forfeiture rate           40.18% 28.25% 40.21%      
Forfeiture Rate Four                      
Accounting Policies [Line Items]                      
Fair value assumptions, forfeiture rate             37.49% 49.45%      
Performance-Based Awards                      
Accounting Policies [Line Items]                      
Compensation cost related to stock options | $           $ 600,000 $ 200,000        
International | Maximum                      
Accounting Policies [Line Items]                      
Product warrant period           24 months 24 months        
Series F Convertible Preferred Stock                      
Accounting Policies [Line Items]                      
Conversion Of Preferred Stock Into Common Stock                     18,000
Preferred stock, shares outstanding               251      
Sale of stock, net, shares               1,000      
Series H Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Convertible preferred stock, shares issued and sold           5,000          
Preferred stock, par value | $ / shares     $ 0.001 $ 0.001   $ 0.001          
Preferred stock, shares issued           5,000          
Preferred stock, shares outstanding           5,000          
Warrants And Rights Outstanding | $       $ 50,000              
Combined purchase price of share and warrant | $ / shares     0.5 $ 0.5              
Conversion Ratio       3.58              
Exercise price of warrants per share | $ / shares     13 $ 13              
Temporary conversion of warrants into share           20,000          
Temporary conversion of preferred stock into common stock           190,000          
Stock Issued During Period Value Preferred Stock Warrants | $           $ (615,000)          
Conversion of convertible preferred stock | $           $ 13,154,000          
Shares issuable upon exercise of warrants           67,500          
Series H Warrants [Member]                      
Accounting Policies [Line Items]                      
Temporary conversion of warrants into share           40,000          
Series J Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Convertible preferred stock, shares issued and sold           14,606          
Preferred stock, par value | $ / shares $ 0.001 $ 0.001                  
Convertible preferred stock, shares issued upon conversion           3,091          
Preferred stock, shares issued           14,606          
Preferred stock, shares outstanding           14,606          
Warrants And Rights Outstanding | $   $ 100,000                  
Combined purchase price of share and warrant | $ / shares 0.5 $ 0.5                  
Conversion Ratio   30.67                  
Exercise price of warrants per share | $ / shares 30 $ 30                  
Temporary conversion of warrants into share           2,980          
Temporary conversion of preferred stock into common stock           66,465          
Shares issuable upon exercise of warrants           34,520          
Series J Warrants [Member]                      
Accounting Policies [Line Items]                      
Temporary conversion of warrants into share           5,960          
Private Placement                      
Accounting Policies [Line Items]                      
Temporary equity numbers of shares sold         4,320            
Exercise price of warrants per share | $ / shares         $ 1,288            
Public Offering                      
Accounting Policies [Line Items]                      
Combined purchase price of share and warrant | $ / shares         $ 1,600            
Public Offering | Series H Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Sale of stock, net, shares       175,000              
Exercise price of warrants per share | $ / shares     $ 26 $ 26              
Public Offering | Series J Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Sale of stock, net, shares   75,000                  
Exercise price of warrants per share | $ / shares $ 60 $ 60                  
Mezzanine Equity | Series F Convertible Preferred Stock                      
Accounting Policies [Line Items]                      
Preferred stock, shares outstanding                   1,000  
Mezzanine Equity | Series H Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Preferred stock, shares outstanding           5,000          
Stock Issued During Period Value Preferred Stock Warrants | $           $ 1,400,000          
Conversion of stock upon amount converted to common stock | $           13,200,000          
Conversion of convertible preferred stock | $           (13,154,000)          
Mezzanine Equity | Series J Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Stock Issued During Period Value Preferred Stock Warrants | $           400,000          
Conversion of convertible preferred stock | $           $ 8,900,000          
BIOLASE Common Stock [Member]                      
Accounting Policies [Line Items]                      
Shares issued           3,416,000 77,000 61,000 5,600 39,000  
Sale of stock, net, shares           503,000 7,000 6,000      
BIOLASE Common Stock [Member] | Series H Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Temporary conversion of preferred stock into common stock           679,542          
Conversion of convertible preferred stock | $           $ 1,000          
BIOLASE Common Stock [Member] | Series J Convertible Preferred Stock [Member]                      
Accounting Policies [Line Items]                      
Temporary conversion of preferred stock into common stock           2,038,804